-
1
-
-
84863518421
-
Overexpression of the autoimmunity-associated phosphatase PTPN22 promotes survival of antigen-stimulated chronic lymphocytic leukemia cells by selectively activating the AKT pathway
-
Negro R, Gobessi S, Longo PG, et al. Overexpression of the autoimmunity-associated phosphatase PTPN22 promotes survival of antigen-stimulated chronic lymphocytic leukemia cells by selectively activating the AKT pathway. Blood. 2012;119(26):6278-6287.
-
(2012)
Blood
, vol.119
, Issue.26
, pp. 6278-6287
-
-
Negro, R.1
Gobessi, S.2
Longo, P.G.3
-
2
-
-
12144291502
-
Afunctional variant of lymphoid tyrosine phosphatase is associated with type 1 diabetes
-
Bottini N, Musumeci L, Alonso A, et al.Afunctional variant of lymphoid tyrosine phosphatase is associated with type 1 diabetes. Nat Genet. 2004;36(4):337-338.
-
(2004)
Nat Genet.
, vol.36
, Issue.4
, pp. 337-338
-
-
Bottini, N.1
Musumeci, L.2
Alonso, A.3
-
3
-
-
84875719184
-
Autoimmunity in primary antibody deficiency is associated with protein tyrosine phosphatase nonreceptor type 22 (PTPN22)
-
[published online ahead of print July 31, 2012]. doi:10.1016/j.jaci.2012. 06.023
-
Chew GYJ, Sinha U, Gatenby PA, et al. Autoimmunity in primary antibody deficiency is associated with protein tyrosine phosphatase nonreceptor type 22 (PTPN22) [published online ahead of print July 31, 2012]. J Allergy Clin Immunol. doi:10.1016/j.jaci.2012.06.023.
-
J Allergy Clin Immunol
-
-
Chew, G.Y.J.1
Sinha, U.2
Gatenby, P.A.3
-
4
-
-
77955504635
-
Lymphoid tyrosine phosphatase and autoimmunity: Human genetics rediscovers phosphatases
-
Stanford SM, Mustelin TM, Bottini N. Lymphoid tyrosine phosphatase and autoimmunity: human genetics rediscovers phosphatases. Semin Immunopathol. 2010;32(2):127-136.
-
(2010)
Semin Immunopathol
, vol.32
, Issue.2
, pp. 127-136
-
-
Stanford, S.M.1
Mustelin, T.M.2
Bottini, N.3
-
5
-
-
65449176044
-
Cutting edge: The PTPN22 alleleic variant associated with autoimmunity impairs B cell signaling
-
Arechiga AF, Habib T, He Y, et al. Cutting edge: the PTPN22 alleleic variant associated with autoimmunity impairs B cell signaling. J Immunol. 2009;182:3343-3347.
-
(2009)
J Immunol.
, vol.182
, pp. 3343-3347
-
-
Arechiga, A.F.1
Habib, T.2
He, Y.3
-
6
-
-
77956216562
-
Autoimmune-associated PTPN22 R620W variation reduces phosphorylation of lymphoid phosphatase on an inhibitory tyrosine residue
-
Fiorillo E, Orru V, Stanford SM, et al. Autoimmune-associated PTPN22 R620W variation reduces phosphorylation of lymphoid phosphatase on an inhibitory tyrosine residue. J Biol Chem. 2010;285(34):26506-26518.
-
(2010)
J Biol Chem.
, vol.285
, Issue.34
, pp. 26506-26518
-
-
Fiorillo, E.1
Orru, V.2
Stanford, S.M.3
-
7
-
-
80052239824
-
The autoimmune disease-associated PTPN22 variant promotes calpain-mediated Lyp/Pep degredation associated with lymphocyte and dendritic cell hyperresponsiveness
-
Zhang J, Zahir N, Jiang Q, et al. The autoimmune disease-associated PTPN22 variant promotes calpain-mediated Lyp/Pep degredation associated with lymphocyte and dendritic cell hyperresponsiveness. Nat Genet. 2011;43(9):902-907.
-
(2011)
Nat Genet.
, vol.43
, Issue.9
, pp. 902-907
-
-
Zhang, J.1
Zahir, N.2
Jiang, Q.3
-
8
-
-
80052376347
-
The PTPN22 allele encoding an R620W variant interferes with the removal of developing autoreactive B cells in humans
-
Menard L, Saadoun D, Isnardi I, et al. The PTPN22 allele encoding an R620W variant interferes with the removal of developing autoreactive B cells in humans. J Clin Invest. 2011;121(9):3635-3644.
-
(2011)
J Clin Invest.
, vol.121
, Issue.9
, pp. 3635-3644
-
-
Menard, L.1
Saadoun, D.2
Isnardi, I.3
-
9
-
-
27644529477
-
Marshfield Clinic Personalized Medicine Research Project (PMRP): Design, methods and recruitment for a large population-based biobank
-
McCarty CA, Wilke RA, Giampietro PF, Wesbrook SD, Caldwell MD. Marshfield Clinic Personalized Medicine Research Project (PMRP): design, methods and recruitment for a large population-based biobank. Per Med. 2005;2:49-79.
-
(2005)
Per Med
, vol.2
, pp. 49-79
-
-
McCarty, C.A.1
Wilke, R.A.2
Giampietro, P.F.3
Wesbrook, S.D.4
Caldwell, M.D.5
-
10
-
-
79951498059
-
Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLL
-
Slager SL, Rabe KG, Achenbach SJ, et al. Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLL. Blood. 2011;117(6):1911-1916.
-
(2011)
Blood.
, vol.117
, Issue.6
, pp. 1911-1916
-
-
Slager, S.L.1
Rabe, K.G.2
Achenbach, S.J.3
|